Trials / Conditions / Osteoporosis, Postmenopausal

Osteoporosis, Postmenopausal

145 registered clinical trials studyying Osteoporosis, Postmenopausal — 17 currently recruiting.

Status	Trial	Sponsor	Phase
Not Yet Recruiting	Telerehabilitation Versus Traditional Balance Training in Women With Osteoporosis. NCT07148479	Riphah International University	N/A
Recruiting	Effect of Mechanical Loading and Bone Loss on Motor Neuron Activity-H-Reflex Relationship NCT07253493	Istanbul Physical Medicine Rehabilitation Training and Research Hospital	N/A
Recruiting	Bone Turnover Markers and Treatment Efficacy in Postmenopausal Osteoporosis NCT07242612	Khyber Medical University Peshawar	N/A
Not Yet Recruiting	Evaluation of Osteo-Buddy in Improving Osteoporosis Knowledge NCT07034131	SingHealth Polyclinics	N/A
Recruiting	Effects of Cycle Therapy vs Sequential Therapy With Romosozumab and Denosumab in Postmenopausal Osteoporosis P NCT06938152	National Taiwan University Hospital	Phase 4
Enrolling By Invitation	Evaluation of a Decision Analysis Model in the DASH-Osteo Decision Aid. NCT07120854	Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau	N/A
Not Yet Recruiting	Efficacy of OsteoBor in Postmenopausal Osteoporosis NCT06809816	Tabriz University of Medical Sciences	Phase 2
Recruiting	Combined Anabolic Therapy NCT06558188	Massachusetts General Hospital	Phase 4
Recruiting	Stress Urinary Incontinence and Sarcopenia in Postmenopausal Osteoporosis NCT06655701	Beylikduzu State Hospital	—
Recruiting	New Biomarkers and Therapeutic Targets in Osteoporosis Via Omics Technologies NCT06525688	National and Kapodistrian University of Athens	—
Recruiting	Health Literacy's Impact on Exercise Habits and Medication Adherence in Postmenopausal Osteoporosis NCT06462833	Gazi University	—
Recruiting	Single or Repeat Zoledronate Versus Alendronate Following Denosumab (EUROpean Denosumab Effects Consolidation NCT05575167	424 General Military Hospital	—
Recruiting	Sequential Therapies After Osteoanabolic Treatment NCT06164795	424 General Military Hospital	—
Recruiting	Effects of Time-restricted Eating and Exercise Training on Skeletal Muscle Mass Quantity, Quality and Function NCT05912309	Idoia Labayen	N/A
Recruiting	Virtual perI-/Menopause Registry of AusTrALia NCT06487130	Bespoke Clinical Research	—
Recruiting	Mechanisms of Anabolic Osteoporosis Therapy NCT05688969	Massachusetts General Hospital	N/A
Active Not Recruiting	Treatment With Zoledronate Subsequent to Denosumab in Osteoporosis 2 (ZOLARMAB2) NCT05655013	Aarhus University Hospital	Phase 4
Active Not Recruiting	Comparative Efficacy, Safety, PK, and Immunogenicity Study NCT05853354	Luye Pharma Group Ltd.	Phase 3
Active Not Recruiting	Effect of Anti-osteoporotic Medications on Nonalcoholic Fatty Liver Disease NCT05493761	Aristotle University Of Thessaloniki	Phase 4
Unknown	Effect of Focal Vibration Within a Multicomponent Exercise Program for Older Women With Osteoporosis a Single- NCT05538377	Universitat Internacional de Catalunya	N/A
Unknown	Efficacy of Zoledronic Acid to Prevent Bone Loss Following Denosumab Discontinuation NCT05405894	University of Calgary	—
Completed	Multicenter Study in Postmenopausal Women With Osteoporosis, ALVOBOND NCT05395091	Alvotech Swiss AG	Phase 3
Completed	Assessment of Cortical Bone Mechanics Technology (CBMT) Fracture Discrimination Capability NCT05721898	Ohio University	—
Completed	MAGnesium Effect With ANtiosteoporotic Drugs NCT05328154	University Hospital, Clermont-Ferrand	Phase 2
Unknown	Effectiveness and Safety of EuBone® Capsules for Bone Health in Postmenopausal Women NCT05402852	Shandong University	Phase 4
Completed	The Effect of the Probiotic Strains on Bone Mineral Density in Postmenopausal Women NCT06375668	Nordic Biotic Sp. z o.o.	N/A
Recruiting	Vascular Function, Sarcopenia and Pain in Postmenopausal Osteoporosis NCT05228262	University Hospital, Clermont-Ferrand	N/A
Unknown	Denosumab Biosimilar Injection in Post Menopausal Women With Osteoporosis NCT05419427	Lambda Therapeutic Research Ltd.	Phase 3
Terminated	Effect of GLP-1 Receptor Agonists on Trabecular Bone Score NCT04964388	University of Mississippi Medical Center	Phase 2
Active Not Recruiting	Romosozumab Use to Build Skeletal Integrity NCT05058976	Susan L. Greenspan	Phase 4
Completed	Effect of Laser Acupuncture on Forearm Bone Mineral Density and Wrist Pain in Osteoporotic Postmenopausal Wome NCT05559619	Cairo University	N/A
Completed	Real-world Effectiveness and Cardiovascular Safety Study of Abaloparatide in Postmenopausal Women NCT04974723	Radius Health, Inc.	—
Unknown	EFFECT OF FLOW RESTRICTION ON BONE QUALITY WITHIN A MULTICOMPONENT EXERCISE PROGRAM FOR OLDER WOMEN WITH OSTEO NCT04760145	Universitat Internacional de Catalunya	N/A
Completed	ValoRization of Dairy Sidestreams to Fight Calcium dEficits iN Postmenopausal Women NCT04836637	University of Copenhagen	N/A
Unknown	The Effects of Melatonin Treatment on Bone, Marrow, Sleep and Blood Pressure NCT04864509	University of Aarhus	Phase 4
Completed	A Study to Test if TVB-009P is Effective in Relieving Postmenopausal Osteoporosis NCT04729621	Teva Pharmaceuticals USA	Phase 3
Active Not Recruiting	Abaloparatide Added to Ongoing Denosumab vs Continued Denosumab Alone NCT04467983	Hospital for Special Surgery, New York	Phase 4
Completed	Evaluation of the Prognostic Role of the Systemic Immune Inflammation Index in Postmenopausal Osteoporosis NCT04748029	Ufuk University	—
Completed	Effect of Vitamin D and Denosumab on Bone Remodelling in Women With Postmenopausal Osteoporosis NCT05372224	Hospital Regional 1o de Octubre	N/A
Completed	Comparing of the Pharmacokinetic, Pharmacodynamic, Safety and Immunogenicity of MW031 and Prolia® in Healthy A NCT04798313	Mabwell (Shanghai) Bioscience Co., Ltd.	Phase 1
Terminated	Intervention on Osteoporosis and Chronic Kidney Disease-mineral and Bone Disorder (CKD-MBD) NCT04271605	National Taiwan University Hospital	N/A
Completed	Coral Calcium's Effect on Bone Density in Postmenopausal Women With and Without Ibandronate NCT04321837	Columbia University	Phase 2
Completed	Efficacy and Safety of MW031 in PMO Subjects NCT05215977	Mabwell (Shanghai) Bioscience Co., Ltd.	Phase 3
Terminated	Menopause Osteoporosis and Bone Intervention Using Lifestyle Exercise. NCT04469374	Staffordshire University	N/A
Completed	Quercetin's Effect on Bone Health and Inflammatory Markers NCT05371340	Kennesaw State University	N/A
Unknown	Association of Cystatin C and Bone Mineral Density in Diabetic Patients. NCT04019938	Fifth Affiliated Hospital, Sun Yat-Sen University	—
Completed	Psychological Determinants of the Therapeutic Observance of Osteoporotic Patients NCT04029870	Centre Hospitalier Régional Metz-Thionville	—
Completed	Circulating Myokine Levels and Bone Metabolism NCT04206618	424 General Military Hospital	—
Completed	Assessing the Effect of Shatavari Supplementation on Bone and Skeletal Muscle Health in Healthy Postmenopausal NCT05025917	University of Exeter	N/A
Completed	Bindex for Osteoporosis Diagnostics NCT03878732	Bone Index Finland Ltd	—
Completed	Hearing Loss and Osteoporosis NCT03895333	Kanuni Sultan Suleyman Training and Research Hospital	—
Completed	MRI Study of the Distal Radius Bone Marrow Fat Fraction in Osteoporotic and Healthy Women NCT03742362	Uri Nevo	N/A
Completed	Efficacy and Safety of the Physical Activity Program in Women With Post-menopausal Osteoporosis NCT04179903	Istituto Ortopedico Rizzoli	N/A
Withdrawn	Activity of Pre-Osteoclasts and Osteoclasts Over Time in Postmenopausal Women Treated With Denosumab or Zoledr NCT03812367	University of California, Davis	—
Active Not Recruiting	Comparative Antiresorptive Efficacy Discontinuation of Denosumab NCT03623633	Massachusetts General Hospital	Phase 4
Completed	Milk Protein and Bone Health in Postmenopausal Women NCT03701113	University of Limerick	N/A
Completed	Use of Ibandronate in Diabetic Patients NCT05266261	Yeouido St. Mary's Hospital	N/A
Completed	Early Effects of Abaloparatide on Tissue-Based Indices of Bone Formation and Resorption NCT03710889	Radius Health, Inc.	Phase 3
Completed	Circulating miRNA in Primary Hyperparathyroidism NCT03931109	University of Pennsylvania	—
Unknown	Sarcopenia And Balance In Postmenopausal Osteoporosis NCT03832088	Istanbul Medeniyet University	N/A
Unknown	Validity of Korebalance Balance System NCT03832075	Istanbul Medeniyet University	N/A
Completed	Dental Panoramic Radiographs to Screen for Post-menopausal Osteoporosis NCT03304743	University of Parma	—
Unknown	Effect of Alendronate 70mg Formulation on Bone Turnover Markers and Patient Reported Outcomes NCT03435094	Labatec Pharma SA	—
Completed	DHEA Augmentation of Musculoskeletal Adaptations to Exercise in Older Women NCT03227458	University of Colorado, Denver	N/A
Completed	Effects of Vitamin D Supplementation in Muscle Strength and Balance Training NCT03367585	University of Sao Paulo General Hospital	N/A
Unknown	A Clinical Trial to Evaluate the Safety and Pharmacokinetic NCT03475719	Huons Co., Ltd.	Phase 1
Completed	Nutritional Supplement and Bone Health in Post-Menopausal Women NCT03337971	University of Limerick	N/A
Completed	STRONG - Study of AGN1 LOEP for the Treatment of the Contralateral Femur After Fragility Fracture NCT03268356	AgNovos Healthcare, LLC	N/A
Withdrawn	Effect of Mechanical Loading With PTH on Cortical Bone NCT03232476	Massachusetts General Hospital	Phase 4
Completed	Tart Cherry Supplementation and Women's Bone Health Study NCT04167150	Oklahoma State University	N/A
Unknown	Generic Zoledronic Acid Versus Original Zoledronic Acid in Postmenopausal Osteoporotic Women NCT03158246	Cttq	Phase 4
Completed	Validation, Reliability and Pilot Test of the Personalized Exercise Questionnaire (PEQ) NCT03125590	McMaster University	—
Unknown	Sarcopenia and Risk of Fall in Osteoporotic Postmenopausal Women NCT03382366	I.R.C.C.S Ospedale Galeazzi-Sant'Ambrogio	N/A
Completed	Safety and Pharmacokinetics of Orally Administered Strontium L-Lactate in Healthy Adults NCT03761979	BioLink Life Sciences, Inc.	N/A
Unknown	Effect of Blueberries on Bone Turnover NCT02630797	Purdue University	Phase 1 / Phase 2
Active Not Recruiting	Comparation of Treatment Strategies for OVF: Teriparatide Injection and PVP NCT03692143	Nanfang Hospital, Southern Medical University	—
Unknown	The Effect of High Impact Exercise on Bone and Articular Cartilage in Post-menopausal Women NCT03225703	Loughborough University	N/A
Completed	Peri-implant Bone Changes in Post-menopausal Osteoporotic Women NCT02884401	Queen Mary University of London	N/A
Completed	Alterations of GCF Levels of Sclerostin and DKK-1 in Postmenopausal Osteoporosis NCT04149405	Ondokuz Mayıs University	Phase 4
Completed	Preventing Osteoporosis Using Denosumab NCT02753283	Susan L. Greenspan	Phase 4
Completed	Zoledronic Acid for Osteoporotic Fracture Prevention (ZEST II) NCT02589600	Susan L. Greenspan	Phase 4
Completed	Adherence to Osteoporosis Treatment and Physicians' Perception Regarding Osteoporosis Medication NCT02472782	251 Hellenic Air Force & VA General Hospital	—
Terminated	A Study of 2 Different Formulations of Blosozumab (LY2541546) in Post Menopausal Women NCT02337387	Eli Lilly and Company	Phase 1
Completed	A Study of Blosozumab (LY2541546) in Postmenopausal Female Participants NCT02109042	Eli Lilly and Company	Phase 1
Completed	Denosumab China Phase III Study NCT02014467	GlaxoSmithKline	Phase 3
Completed	Switching From Oral Bisphosphonates to Bazedoxifene to Evaluate Effects on Bone Mineral Density in Postmenopau NCT02090400	Instituto Palacios	Phase 4
Completed	A 5-Year Follow-up Study Investigating Factors Associated With Osteoporotic Fracture in Chinese Postmenopausal NCT02247011	Peking Union Medical College Hospital	N/A
Completed	Pearlium®/Effecti-Cal®, a Novel Formulation of Calcium, Vitamin D and Minerals for Prevention of Postmenopausa NCT04609189	University of Alberta	Phase 4
Completed	Quality of the Detection & Treatment of Osteoporotic Fractures in a Swiss Trauma Center NCT02157753	Kantonsspital Aarau	—
Completed	Prospective Observational Study to Describe Characteristics and Management of Patients Treated With Denosumab NCT01652690	Amgen	—
Completed	Soluble Corn Fiber Effect on Bone Resorption in Post Menopausal Women NCT02416947	Purdue University	N/A
Completed	A Study in Indian Postmenopausal Women With Osteoporosis to Evaluate the Efficacy and Safety of Denosumab NCT01495000	GlaxoSmithKline	Phase 3
Completed	A Study in Korean Postmenopausal Women With Osteoporosis to Evaluate the Efficacy and Safety of Denosumab NCT01457950	GlaxoSmithKline	Phase 3
Completed	Bazedoxifene Post Approval Safety Study (PASS) in the European Union (EU) NCT01416194	Pfizer	—
Completed	A Study to Evaluate Alendronate Sodium /Vitamin D3 Combination Tablets(FOSAMAX PLUS) Versus Calcitriol in the NCT01350934	Organon and Co	Phase 4
Completed	Hesperidin and Bone Health in Postmenopausal Women NCT01881204	Purdue University	N/A
Completed	Effects of Physical Exercise to Prevent Osteoporosis in Postmenopausal Women NCT03091088	University of Valencia	N/A
Completed	A Multiple-Dose Study to Evaluate Skin Irritation and Sensitization of Teriparatide Administered Transdermally NCT01250145	Eli Lilly and Company	Phase 1
Completed	The Prevalence of Osteoporotic Vertebral Compression Fractures (OVCF) in Korean Post Menopausal Women NCT01381588	GlaxoSmithKline	—
Completed	Radius Loading in Primary Hyperparathyroidism NCT01571843	Columbia University	N/A
Completed	Effects of Whole-Body Vibration and High Impact Exercises in Postmenopausal Women NCT03910348	Istanbul University	N/A
Completed	A Study to Evaluate Food Effect on ONO-5920/YM529 Intermittent Formulation NCT00965978	Astellas Pharma Inc	Phase 1
Completed	A Study Comparing Oral Calcitonin to Nasal Spray Calcitonin in Postmenopausal Osteoporotic Women NCT00959764	Tarsa Therapeutics, Inc.	Phase 3
Completed	Wellnara Post-marketing Surveillance in Japan NCT01401114	Bayer	—
Completed	Julina Post-marketing Surveillance for Postmenopausal Osteoporosis in Japan NCT01397955	Bayer	—
Completed	Julina Post-marketing Surveillance for Climacteric Symptoms in Japan NCT01386281	Bayer	—
Completed	A Study for Teriparatide in Severe Osteoporosis NCT00696644	Eli Lilly and Company	—
Completed	Quality of Life(QoL) in Korean Postmenopausal Osteoporosis Patients With Bisphosphonate Treatment NCT01227369	GlaxoSmithKline	—
Completed	Efficacy and Safety Study of Fosamax Plus D in Postmenopausal Women With Osteoporosis (0217A-263) NCT00729651	Organon and Co	Phase 4
Completed	Efficacy and Safety of Odanacatib (MK-0822) in Participants With Involutional Osteoporosis (MK-0822-022) NCT00620113	Merck Sharp & Dohme LLC	Phase 2
Completed	A Study Using Imaging Technology to Measure Changes in Bone Structure After Treatment With Teriparatide NCT00557310	Eli Lilly and Company	Phase 4
Completed	Angeliq Regulatory Post Marketing Surveillance NCT01064453	Bayer	—
Completed	Parameters of Exercise to Prevent Osteoporosis NCT04063813	University of Michigan	N/A
Completed	Study To Investigate Patient Preference On Dosing In Ibandronate And Risedronate In Korean Women With Postmeno NCT00405392	GlaxoSmithKline	Phase 4
Completed	Study Comparing Arzoxifene With Raloxifene in Women After Menopause With Osteoporosis NCT00383422	Eli Lilly and Company	Phase 3
Completed	The Effects of Potassium Citrate on Bone Metabolism NCT00357331	Weill Medical College of Cornell University	Phase 4
Completed	Effect of Teriparatide Compared to Risedronate on Back Pain in Women With a Spine Fracture Caused by Osteoporo NCT00343252	Eli Lilly and Company	Phase 3
Completed	Impact of Oral Ibandronate 150 mg Monthly on Structural Properties of Bone in Postmenopausal Osteoporosis (SPI NCT00271713	Charite University, Berlin, Germany	Phase 4
Completed	Optimizing Body Composition & Health After Breast Cancer NCT00659906	OHSU Knight Cancer Institute	N/A
Completed	Strength Training for Older Breast Cancer Survivors NCT00591747	OHSU Knight Cancer Institute	N/A
Completed	3-Week Parathyroid Hormone-related Protein (PTHrP) Dose Escalation Study in Post-Menopausal Women NCT00222872	University of Pittsburgh	Phase 1
Completed	Risedronate 75mg Dosed on 2 Consecutive Days Monthly in the Treatment of Osteoporosis in Postmenopausal Women NCT00358176	Sanofi	Phase 3
Completed	Effects of Arzoxifene on Bone Fractures and Incidence of Breast Cancer NCT00088010	Eli Lilly and Company	Phase 3
Terminated	Risedronate vs Raloxifene in Hormone Replacement Therapy Discontinuation NCT00790101	Sanofi	Phase 4
Completed	A Study to Determine the Satisfaction With Actonel in Postmenopausal Women With Osteoporosis NCT00632216	Sanofi	Phase 4
Completed	OPTAMISE: Clinical Effectiveness of Teriparatide After Alendronate or Risedronate Therapy in Osteoporotic Post NCT00130403	Sanofi	Phase 4
Completed	Risedronate Sodium in Post Menopausal Osteoporosis NCT00453492	Sanofi	Phase 4
Completed	Satisfaction and Compliance of Risedronate in PMO NCT00549965	Sanofi	Phase 4
Completed	Patient- and Physician-Based Osteoporosis Education NCT00073190	Brigham and Women's Hospital	Phase 1
Completed	Comparison Medications in the Treatment of Postmenopausal Women With Osteoporosis NCT00542984	Eli Lilly and Company	Phase 3
Completed	Influence of Alfacalcidol on Falls in Osteopenic/Osteoporotic Postmenopausal Women (ALFA Study) NCT00168909	Charite University, Berlin, Germany	Phase 4
Completed	A Study and 12 Month Extension to Evaluate Two Investigational Drugs in Postmenopausal Women With Osteoporosis NCT00092040	Organon and Co	Phase 3
Completed	POWER Point of Care Effect on Satisfaction of Treatment NCT00549068	Sanofi	Phase 4
Completed	Risedronate In The Prevention Of Osteoporosis In Osteopenic Postmenopausal Women NCT00353080	Sanofi	Phase 3
Completed	Risedronate in Postmenopausal Women With Low Bone Density NCT00351091	Sanofi	Phase 2
Completed	Risedronate in the Prevention of Osteoporosis in Postmenopausal Women NCT00402441	Sanofi	Phase 4
Completed	2-Year Therapy With Teriparatide vs 1-yr Therapy Followed by 1-Year of Raloxifene or Calcium/Vit D in Severe P NCT00191425	Eli Lilly and Company	Phase 4
Completed	Sequential Use of Teriparatide and Raloxifene HCl in the Treatment of Postmenopausal Women With Osteoporosis NCT00035256	Eli Lilly and Company	Phase 4
Completed	A Comparison Study With Alendronate and Raloxifene in Postmenopausal Women With Osteoporosis (0217-189) NCT00389740	Organon and Co	Phase 3
Completed	Effects of Black Cohosh on Menopausal Hot Flashes NCT00010712	National Center for Complementary and Integrative Health (NCCIH)	Phase 2
Completed	FLEX - Long-term Extension of FIT (Fracture Intervention Trial)(0217-051) NCT00398931	Organon and Co	Phase 3
Completed	Effects of Teriparatide in the Treatment of Postmenopausal Women With Osteoporosis NCT00670501	Eli Lilly and Company	Phase 3
Completed	A Study to Compare the Efficacy of Alendronate With and Without Calcium or Calcium Alone In the Treatment of O NCT00398606	Organon and Co	Phase 3
Completed	Comparison of Raloxifene Hydrochloride and Placebo in the Treatment of Postmenopausal Women With Osteoporosis NCT00670319	Eli Lilly and Company	Phase 3
Completed	Combined Use of Teriparatide and Raloxifene in Postmenopausal Women With Osteoporosis NCT00046137	Eli Lilly and Company	Phase 3